Endpoints News 生物医药· Kyle LaHucik·· 2026-10-06AI 评分45
Lycia Therapeutics 寻求 IPO,TRexBio 与 Retension 达成融资条款
Lycia seeks IPO for antibody degraders as TRexBio, Retension set terms
AI 导读
Lycia Therapeutics 已提交 IPO 申请,该公司专注于抗体降解剂研发。同时,TRexBio 和 Retension 两家公司已达成融资条款。
正文
Lycia Therapeutics, a protein degradation startup built around science out of the lab of Nobel laureate Carolyn Bertozzi, has filed for an initial public offering …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news